When we talk about staplers in China, the first brands that come to mind are Johnson & Johnson and Medtronic. These two companies once occupied more than 90% of the Chinese stapler market. However, with the national centralized procurement and the continuous emergence of high-quality domestic products, their market share is declining significantly. Domestically produced staplers have begun to take the initiative, and in the future, Johnson & Johnson and Medtronic could become "Other."
In China, Johnson & Johnson and Medtronic staplers are on the decline, mainly due to policy reasons. In the United StatesJohnson & Johnson and MedtronicThe market share of surgical staplers is also rapidly declining. According to overseas statistics, Johnson & Johnson and Medtronic are no longer the brands with the highest market share for laparoscopic staplers in the United States.Intuitive Has Quietly Surpassed Medtronic and Johnson & Johnson, Rising to the Top。
The main reason for Intuitive's leading market share in endoscopic staplers is still the tremendous success of the Da Vinci series of soft tissue surgical robots developed by Intuitive. CurrentlyDa Vinci Series Global Always Achieves9,902 units, while in the United States it isThe Da Vinci series has been installed in the most countries. In 2021Da Vinci Series Surgical RobotsAlready covering more than two-thirds of large and medium-sized hospitals in the U.S., and even the coverage rate in community hospitals has reached as high as 72.19%. NowadaysThe proportion of hospitals in the United States covered by the Da Vinci series of surgical robots continues to increase.For example, the Da Vinci 5, which was launched last year, has already been installed over 362 times in the United States and is still in a phase of rapid growth (installation numbers for the four quarters of last year: Q1 with 8 units, Q2 with 70 units, Q3 with 110 units, and Q4 with 174 units).Da Vinci 5 Will DriveMarket share of the Da Vinci series surgical robots in the United States. This will alsoStaplers配套 for the Da Vinci Series Surgical RobotsSureFormMarket share continues to rise.In the future, if Johnson & Johnson and Medtronic want to regain their market share of endoscopic staplers in the U.S., they will need Hugo andOttava is launched in the Chinese market as soon as possible and can demonstrate strong competitiveness.At present, the penetration rate of soft tissue surgical robots in hospitals in China is not high, and once it reaches the same level as in the United States,Penetration Rate,Will the endoscopic stapler also be the same in China as it is in the United States?
SureFormIt is a laparoscopic stapler used in conjunction with the Da Vinci series of surgical robots. It can be divided into three models based on the length of the cartridge: 30, 45, and 60.SureFormAll are integrated with SmartFire software, which intelligently controls the stapling process. SmartFire software optimizes the performance of the staple line by measuring tissue compression before and during stapling, automatically adjusting to optimize the staple line.In additionSureFormOwn uniqueA unique 120-degree wrist joint cone allows doctors to freely approach tissues in their natural position, providing greater mobility to bypass target tissues and reduce tissue tension.
8mm SureForm 30It is the latest generation of SureForm stapler, which is fullyComposed of the wrist, 8mm SureForm 30 cartridge and stapler (gray, white and blue), suitable for general, thoracic, gynecological, urological and pediatric surgeries.8mm SureForm 30The purpose is to combine an 8-millimeter-diameter instrument shaft and jawbone, a 120-degree wrist joint cone, and a curved tip.Help surgeons achieve better visualization and access to anatomical locations.When the stapler passes through the 8mm Da Vinci surgical robot trocar, it allows surgeons to approach the patient's anatomy from different angles.
IntuitiveA California-based medical device company, and a global technology leader in the field of minimally invasive care as well as a pioneer in robot-assisted surgery.InIntuitive, we envision a future of care that is less invasive and more effective, where diseases are caught early and treated quickly so patients can get back to what matters most.
